Market Overview

Kevin Kelly's Allergan Trade

Related AGN
Cramer Shares His Opinion On 8Point3 Energy, PPG Industries And Allergan
Barron's Picks And Pans: Super Chip Stocks, Time Warner And More
Allergan chief Saunders adds Chairman role (Seeking Alpha)

Kevin Kelly of Recon Capital Partners shared with the viewers of Bloomberg Markets his options trade in Allergan plc Ordinary Shares (NYSE: AGN).

The stock is trading more than 25 percent lower year-to-date and Kelly thinks there is a lot of uncertainty in the market right now. He is concerned about a possible impact of the presidential election on the market and there is also the risk associated with the earnings season. The company is going to report earnings on November 2 and Kelly wants to use a stock replacement strategy to reduce the risk.

He thinks it would be a good idea to sell the stock and buy the January 230 call for $12.80. The most he can lose is $12.80 and the break even for the trade is at $242.80 or 6.5 percent higher.

Posted-In: Bloomberg Markets Kevin KellyCNBC Options Markets Media


Related Articles (AGN)

View Comments and Join the Discussion!